{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:51:21Z","timestamp":1787604681019,"version":"build-2736575974"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic syndrome mainly includes obesity, type 2 diabetes (T2DM), alcoholic fatty liver (NAFLD) and cardiovascular diseases. According to the ancient experience philosophy of Yin-Yang, monarch-minister compatibility of traditional Chinese medicine, prescription is given to treat diseases, which has the advantages of small toxic and side effects and quick effect. However, due to the diversity of traditional Chinese medicine ingredients and doubts about the treatment theory of traditional Chinese medicine, the mechanism of traditional Chinese medicine is still in doubt. Gastrointestinal tract is an important part of human environment, and participates in the occurrence and development of diseases. In recent years, more and more TCM researches have made intestinal microbiome a new frontier for understanding and treating diseases. Clinically, nonalcoholic fatty liver disease (NAFLD) and diabetes mellitus (DM) often co-occur. Our aim is to explain the mechanism of interaction between gastrointestinal microbiome and traditional Chinese medicine (TCM) or traditional Chinese medicine formula to treat DM and NAFLD. Traditional Chinese medicine may treat these two diseases by influencing the composition of intestinal microorganisms, regulating the metabolism of intestinal microorganisms and transforming Chinese medicinal compounds.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1072376","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:14:20Z","timestamp":1671758060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine \u2013 a case study of diabetes and nonalcoholic fatty liver disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Yang","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-020-3268-3","article-title":"Intestinal microecology: An important target for Chinese medicine treatment of non-alcoholic fatty liver disease","volume":"26","author":"Li","year":"2020","journal-title":"Chin J Integr Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.958218","article-title":"Gut microbiota: A new target for T2DM prevention and treatment","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/19490976.2015.1024918","article-title":"Type 2 diabetes and gut microbiome: at the intersection of known and unknown","volume":"6","author":"Upadhyaya","year":"2015","journal-title":"Gut Microbes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.855075","article-title":"Gut microbiota: The potential key target of TCM\u2019s therapeutic effect of treating different diseases using the same method\u2013UC and T2DM as examples","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infection Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1787","article-title":"Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: A call to action","volume":"40","author":"Bril","year":"2017","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13643-019-1200-8","article-title":"Diabetes drugs for nonalcoholic fatty liver disease: a systematic review","volume":"8","author":"Blazina","year":"2019","journal-title":"Syst Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0137","article-title":"Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease","volume":"26","author":"Kim","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","author":"American Diabetes","year":"2013","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26988","article-title":"Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis","volume":"59","author":"Bril","year":"2014","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-2803.201900000-45","article-title":"NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN a LIVER DISEASE","volume":"56","author":"Parise","year":"2019","journal-title":"Arq Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.349","article-title":"Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population","volume":"108","author":"Chang","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2020.02.011","article-title":"Fatty liver index and risk of diabetes incidence: A systematic review and dose-response meta-analysis of cohort studies","volume":"14","author":"Movahedian","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109208","article-title":"Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study","volume":"184","author":"Chung","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.06.001","article-title":"Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease","volume":"4","author":"Abdelmalek","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00980-6","article-title":"The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091111","article-title":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity","volume":"9","author":"Woo","year":"2014","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2424","article-title":"Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice","volume":"73","author":"Zamani-Garmsiri","year":"2021","journal-title":"IUBMB Life"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.704112","article-title":"Metformin alleviates steatohepatitis in diet-induced obese mice in a SIRT1-dependent way","volume":"12","author":"Guo","year":"2021","journal-title":"Front Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1349","article-title":"Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa\/fa zucker rats independent of glycemia and body weight","volume":"146","author":"Gedulin","year":"2005","journal-title":"Endocrinology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02462.x","article-title":"Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis","volume":"31","author":"Svegliati-Baroni","year":"2011","journal-title":"Liver Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice","volume":"43","author":"Ding","year":"2006","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031394","article-title":"Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL\/6J mice","volume":"7","author":"Lee","year":"2012","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00274.2011","article-title":"Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL\/6J mice fed a Western diet","volume":"302","author":"Mells","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20181304","article-title":"Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","volume":"38","author":"Tian","year":"2018","journal-title":"Biosci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12933-019-0954-6","article-title":"Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1\/2 pathway","volume":"18","author":"Wu","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0217","article-title":"PPAR\u03b3 deacetylation confers the antiatherogenic effect and improves endothelial function in diabetes treatment","volume":"69","author":"Liu","year":"2020","journal-title":"Diabetes"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14434","article-title":"Metabolomic and lipidomic analysis of the effect of pioglitazone on hepatic steatosis in a rat model of obese type 2 diabetes","volume":"175","author":"Yang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): Structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00592-020-01652-z","article-title":"Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model","volume":"58","author":"Han","year":"2021","journal-title":"Acta Diabetol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jsfa.11202","article-title":"Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases","volume":"101","author":"Sun","year":"2021","journal-title":"J Sci Food Agric"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.625913","article-title":"Role and mechanism of gut microbiota in human disease","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101363","article-title":"Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes","volume":"48","author":"Lembo","year":"2022","journal-title":"Diabetes Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/nu12030820","article-title":"Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: A cross-sectional study in Taiwan","volume":"12","author":"Tsai","year":"2020","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1025706","article-title":"The critical role of gut microbiota in obesity","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2009752","article-title":"Gut microbiome-based diagnostic model to predict diabetes mellitus","volume":"12","author":"Yang","year":"2021","journal-title":"Bioengineered"},{"key":"B41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/biology10040348","article-title":"Lactobacillus sps in reducing the risk of diabetes in high-fat diet-induced diabetic mice by modulating the gut microbiome and inhibiting key digestive enzymes associated with diabetes","volume":"10","author":"Gulnaz","year":"2021","journal-title":"Biol (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2078612","article-title":"Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis","volume":"14","author":"Kang","year":"2022","journal-title":"Gut Microbes"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2089006","article-title":"Recovery of bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease","volume":"14","author":"Sangineto","year":"2022","journal-title":"Gut Microbes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2016.1245650","article-title":"Short-chain fatty acids in control of energy metabolism","volume":"58","author":"Hu","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/nu7042839","article-title":"Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation","volume":"7","author":"Kasubuchi","year":"2015","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13316","article-title":"Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease","volume":"22","author":"Zhang","year":"2021","journal-title":"Obes Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/cells11040750","article-title":"Free fatty acid receptors (FFARs) in adipose: Physiological role and therapeutic outlook","volume":"11","author":"Al Mahri","year":"2022","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.656441","article-title":"Free fatty acid receptors as mediators and therapeutic targets in liver disease","volume":"12","author":"Secor","year":"2021","journal-title":"Front Physiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.03.011","article-title":"SCFA receptors in pancreatic \u03b2 cells: Novel diabetes targets","volume":"27","author":"Priyadarshini","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00265.2013","article-title":"Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids","volume":"305","author":"den Besten","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170012","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.abb.2019.07.022","article-title":"Propionate suppresses hepatic gluconeogenesis via GPR43\/AMPK signaling pathway","volume":"672","author":"Yoshida","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0545","article-title":"Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43","volume":"146","author":"Hong","year":"2005","journal-title":"Endocrinology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5110276","article-title":"Gut microbiota and type 2 diabetes mellitus: Association, mechanism, and translational applications","volume":"2021","author":"Zhang","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41598-017-18259-0","article-title":"SCFAs strongly stimulate PYY production in human enteroendocrine cells","volume":"8","author":"Larraufie","year":"2018","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-021-02491-6","article-title":"Can diet modulate trimethylamine n-oxide (TMAO) production? what do we know so far","volume":"60","author":"Coutinho-Wolino","year":"2021","journal-title":"Eur J Nutr"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/nu12082340","article-title":"The relationship between choline bioavailability from diet, intestinal microbiota composition, and its modulation of human diseases","volume":"12","author":"Arias","year":"2020","journal-title":"Nutrients"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.733507","article-title":"Trimethylamine-N-Oxide pathway: A potential target for the treatment of MAFLD","volume":"8","author":"Li","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3390\/nu14102093","article-title":"Association between plasma trimethylamine n-oxide levels and type 2 diabetes: A case control study","volume":"14","author":"Kalagi","year":"2022","journal-title":"Nutrients"},{"key":"B62","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12967-022-03581-7","article-title":"Serum trimethylamine-n-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study","volume":"20","author":"Li","year":"2022","journal-title":"J Transl Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"101183","DOI":"10.1016\/j.diabet.2020.07.010","article-title":"Trimethylamine n-oxide levels are associated with NASH in obese subjects with type 2 diabetes","volume":"47","author":"Le\u00f3n-Mimila","year":"2021","journal-title":"Diabetes Metab"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/biom11121892","article-title":"Gut metabolite trimethylamine n-oxide protects INS-1 \u03b2-cell and rat islet function under diabetic glucolipotoxic conditions","volume":"11","author":"Krueger","year":"2021","journal-title":"Biomolecules"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i22.3010","article-title":"Role of bile acids in liver diseases mediated by the gut microbiome","volume":"27","author":"Shao","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112839","article-title":"Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus","volume":"149","author":"Du","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101493","article-title":"Gut microbiome and bile acids in obesity-related diseases","volume":"35","author":"Li","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine l cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.011913","article-title":"Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice","volume":"295","author":"Takahashi","year":"2020","journal-title":"J Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.932670","article-title":"The role of branched-chain amino acids and branched-chain \u03b1-keto acid dehydrogenase kinase in metabolic disorders","volume":"9","author":"Du","year":"2022","journal-title":"Front Nutr"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/biom11101414","article-title":"Gut microbiota as the link between elevated BCAA serum levels and insulin resistance","volume":"11","author":"Gojda","year":"2021","journal-title":"Biomolecules"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.920277","article-title":"Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/nu13072229","article-title":"Amino acid-induced impairment of insulin signaling and involvement of G-protein coupling receptor","volume":"13","author":"Zakaria","year":"2021","journal-title":"Nutrients"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.3390\/ijms23084325","article-title":"Role of branched-chain amino acid metabolism in type 2 diabetes, obesity, cardiovascular disease and non-alcoholic fatty liver disease","volume":"23","author":"Cuomo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/biomedicines10061444","article-title":"The emerging role of branched-chain amino acids in liver diseases","volume":"10","author":"Lo","year":"2022","journal-title":"Biomedicines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"18768","DOI":"10.1038\/s41598-020-75542-3","article-title":"Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid","volume":"10","author":"Iwao","year":"2020","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/biomedicines10010083","article-title":"Intestinal barrier and permeability in health, obesity and NAFLD","volume":"10","author":"Portincasa","year":"2021","journal-title":"Biomedicines"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.13166","article-title":"High-fat diet-induced intestinal hyperpermeability is associated with increased bile acids in the Large intestine of mice","volume":"81","author":"Murakami","year":"2016","journal-title":"J Food Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1985.249.5.R551","article-title":"Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration","volume":"249","author":"Cornell","year":"1985","journal-title":"Am J Physiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.775526","article-title":"The gut-liver axis in health and disease: The role of gut microbiota-derived signals in liver injury and regeneration","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","article-title":"Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88","volume":"195","author":"Guo","year":"2015","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23917","article-title":"The role of intestinal endotoxin in liver injury: a long and evolving history","volume":"52","author":"Nolan","year":"2010","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/nu12092762","article-title":"New insights into the pathogenesis of non-alcoholic fatty liver disease: Gut-derived lipopolysaccharides and oxidative stress","volume":"12","author":"Ferro","year":"2020","journal-title":"Nutrients"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000745","article-title":"Lycium ruthenicum anthocyanins attenuate high-fat diet-induced colonic barrier dysfunction and inflammation in mice by modulating the gut microbiota","volume":"65","author":"Tian","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2021.1893338","article-title":"The role of resveratrol in diabetes and obesity associated with insulin resistance","author":"Hoca","year":"2021","journal-title":"Arch Physiol Biochem"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01249","article-title":"Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice","volume":"11","author":"Cai","year":"2020","journal-title":"Front Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2013.11.016","article-title":"Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation","volume":"30","author":"Andrade","year":"2014","journal-title":"Nutrition"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.611323","article-title":"Resveratrol improves liver steatosis and insulin resistance in non-alcoholic fatty liver disease in association with the gut microbiota","volume":"12","author":"Du","year":"2021","journal-title":"Front Microbiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7589","article-title":"Pharmacokinetic of berberine, the main constituent of berberis vulgaris l.: A comprehensive review","volume":"36","author":"Khoshandam","year":"2022","journal-title":"Phytother Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113542","article-title":"Dual modulation of gut bacteria and fungi manifests the gut-based anti-hyperlipidemic effect of coptidis rhizoma","volume":"153","author":"Yang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.854885","article-title":"The mechanism of berberine alleviating metabolic disorder based on gut microbiome","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4611-5","article-title":"Plasma branched chain\/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED trial","volume":"61","author":"Ruiz-Canela","year":"2018","journal-title":"Diabetologia"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110669","article-title":"Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids","volume":"131","author":"Yao","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000215","article-title":"The hypoglycemic effect of berberine and berberrubine involves modulation of intestinal farnesoid X receptor signaling pathway and inhibition of hepatic gluconeogenesis","volume":"49","author":"Sun","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.913378","article-title":"Berberrubine, a main metabolite of berberine, alleviates non-alcoholic fatty liver disease via modulating glucose and lipid metabolism and restoring gut microbiota","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.853981","article-title":"Gut microbiota: Therapeutic targets of ginseng against multiple disorders and ginsenoside transformation","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e14321","DOI":"10.1111\/jfbc.14321","article-title":"Ginsenoside Rg1 improved diabetes through regulating the intestinal microbiota in high-fat diet and streptozotocin-induced type 2 diabetes rats","volume":"46","author":"Peng","year":"2022","journal-title":"J Food Biochem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.0c06279","article-title":"Xylooligosaccharides increase bifidobacteria and lachnospiraceae in mice on a high-fat diet, with a concomitant increase in short-chain fatty acids, especially butyric acid","volume":"69","author":"Berger","year":"2021","journal-title":"J Agric Food Chem"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.0c00605","article-title":"Hypoglycemic effect of ginsenoside Rg5 mediated partly by modulating gut microbiota dysbiosis in diabetic db\/db mice","volume":"68","author":"Wei","year":"2020","journal-title":"J Agric Food Chem"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.0c04429","article-title":"Dietary ginsenoside T19 supplementation regulates glucose and lipid metabolism via AMPK and PI3K pathways and its effect on intestinal microbiota","volume":"68","author":"Xu","year":"2020","journal-title":"J Agric Food Chem"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3390\/nu12103179","article-title":"Curcumin: Could this compound be useful in pregnancy and pregnancy-related complications","volume":"12","author":"Filardi","year":"2020","journal-title":"Nutrients"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7404","article-title":"Curcumin regulates the homeostasis of Th17\/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis","volume":"36","author":"Xiao","year":"2022","journal-title":"Phytother Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104665","article-title":"Tetrahydrocurcumin ameliorates diabetes profiles of db\/db mice by altering the composition of gut microbiota and up-regulating the expression of GLP-1 in the pancreas","volume":"146","author":"Yuan","year":"2020","journal-title":"Fitoterapia"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/16546628.2017.1379861","article-title":"Polygala tenuifolia extract inhibits lipid accumulation in 3T3-L1 adipocytes and high-fat diet-induced obese mouse model and affects hepatic transcriptome and gut microbiota profiles","volume":"61","author":"Wang","year":"2017","journal-title":"Food Nutr Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.110945","article-title":"Licorice extract ameliorates hyperglycemia through reshaping gut microbiota structure and inhibiting TLR4\/NF-kappaB signaling pathway in type 2 diabetic mice","volume":"153","author":"Zhang","year":"2022","journal-title":"Food Res Int"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153477","article-title":"Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix scutellariae as a case","volume":"83","author":"Zhao","year":"2021","journal-title":"Phytomedicine"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109591","article-title":"Prebiotic, immuno-stimulating and gut microbiota-modulating effects of lycium barbarum polysaccharide","volume":"121","author":"Zhu","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.05.209","article-title":"A homogeneous polysaccharide from lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota","volume":"183","author":"Yang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.05.020","article-title":"Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system","volume":"39","author":"Chen","year":"2020","journal-title":"Clin Nutr"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113995","article-title":"Berberis kansuensis extract alleviates type 2 diabetes in rats by regulating gut microbiota composition","volume":"273","author":"Xu","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2009322","article-title":"Improvement of intestinal barrier function, gut microbiota, and metabolic endotoxemia in type 2 diabetes rats by curcumin","volume":"12","author":"Huang","year":"2021","journal-title":"Bioengineered"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109559","article-title":"Lycium barbarum l. leaves ameliorate type 2 diabetes in rats by modulating metabolic profiles and gut microbiota composition","volume":"121","author":"Zhao","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S288011","article-title":"Cinnamaldehyde improves metabolic functions in streptozotocin-induced diabetic mice by regulating gut microbiota","volume":"15","author":"Zhao","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/molecules23123245","article-title":"Effects of rich-polyphenols extract of dendrobium loddigesii on anti-diabetic, anti-inflammatory, anti-oxidant, and gut microbiota modulation in db\/db mice","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114558","article-title":"Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK\/SIRT1 and PI3K\/AKT pathway","volume":"281","author":"Gong","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154444","article-title":"Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling","volume":"107","author":"Zhai","year":"2022","journal-title":"Phytomedicine"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1039\/d0fo02100h","article-title":"Laminaria japonica polysaccharide prevents high-fat-diet-induced insulin resistance in mice via regulating gut microbiota","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1039\/c7fo01346a","article-title":"Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db\/db mice","volume":"9","author":"Chen","year":"2018","journal-title":"Food Funct"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9734560","article-title":"Chicoric acid ameliorates nonalcoholic fatty liver disease via the AMPK\/Nrf2\/NF\u03baB signaling pathway and restores gut microbiota in high-Fat-Diet-Fed mice","volume":"2020","author":"Ding","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.558525","article-title":"Inulin exerts beneficial effects on non-alcoholic fatty liver disease via modulating gut microbiome and suppressing the lipopolysaccharide-Toll-Like receptor 4-M\u03c8-Nuclear factor-\u03baB-Nod-Like receptor protein 3 pathway via gut-liver axis in mice","volume":"11","author":"Bao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/nu12102932","article-title":"Rhubarb supplementation prevents diet-induced obesity and diabetes in association with increased akkermansia muciniphila in mice","volume":"12","author":"Regnier","year":"2020","journal-title":"Nutrients"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111441","article-title":"Akebia saponin d ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury","volume":"138","author":"Yang","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.14058","article-title":"Green tea polyphenols modulate colonic microbiota diversity and lipid metabolism in high-fat diet treated HFA mice","volume":"83","author":"Wang","year":"2018","journal-title":"J Food Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201800930","article-title":"Functional interactions between gut microbiota transplantation, quercetin, and high-fat diet determine non-alcoholic fatty liver disease development in germ-free mice","volume":"63","author":"Porras","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1039\/d1fo03219d","article-title":"Ganoderic acid a from ganoderma lucidum protects against alcoholic liver injury through ameliorating the lipid metabolism and modulating the intestinal microbial composition","volume":"13","author":"Lv","year":"2022","journal-title":"Food Funct"},{"key":"B128","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ijbiomac.2019.11.047","article-title":"Intake of ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats","volume":"155","author":"Chen","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.984695","article-title":"Morchella esculenta mushroom polysaccharide attenuates diabetes and modulates intestinal permeability and gut microbiota in a type 2 diabetic mice model","volume":"9","author":"Rehman","year":"2022","journal-title":"Front Nutr"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154423","article-title":"Laurolitsine ameliorates type 2 diabetes by regulating the hepatic LKB1-AMPK pathway and gut microbiota","volume":"106","author":"Yong","year":"2022","journal-title":"Phytomedicine"},{"key":"B131","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12906-020-2835-7","article-title":"Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with gynostemma pentaphyllum in rats","volume":"20","author":"Shen","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.885039","article-title":"Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2\/NLRP3 pathway","volume":"13","author":"Yue","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154208","article-title":"The improvement of nonalcoholic steatohepatitis by poria cocos polysaccharides associated with gut microbiota and NF-\u03baB\/CCL3\/CCR1 axis","volume":"103","author":"Tan","year":"2022","journal-title":"Phytomedicine"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1039\/d2fo01009g","article-title":"Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats","volume":"13","author":"Zhong","year":"2022","journal-title":"Food Funct"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111401","article-title":"Pueraria lobata starch regulates gut microbiota and alleviates high-fat high-cholesterol diet induced non-alcoholic fatty liver disease in mice","volume":"157","author":"Yang","year":"2022","journal-title":"Food Res Int"},{"key":"B136","doi-asserted-by":"publisher","first-page":"10620","DOI":"10.3390\/ijms231810620","article-title":"Polysaccharide from salviae miltiorrhizae radix et rhizoma attenuates the progress of obesity-induced non-alcoholic fatty liver disease through modulating intestinal microbiota-related gut-liver axis","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.2c04817","article-title":"Nuciferine protects against high-fat diet-induced hepatic steatosis via modulation of gut microbiota and bile acid metabolism in rats","volume":"70","author":"Sun","year":"2022","journal-title":"J Agric Food Chem"},{"key":"B138","doi-asserted-by":"publisher","first-page":"104859","DOI":"10.1016\/j.jff.2021.104859","article-title":"Nuciferine prevents hepatic steatosis associated with improving intestinal mucosal integrity, mucus-related microbiota and inhibiting TLR4\/MyD88\/NF-\u03baB pathway in high-fat induced rats","volume":"88","author":"Fan","year":"2022","journal-title":"J Funct Foods"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/nu14091699","article-title":"Myristica fragrans extract regulates gut microbes and metabolites to attenuate hepatic inflammation and lipid metabolism disorders via the AhR-FAS and NF-kappaB signaling pathways in mice with non-alcoholic fatty liver disease","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112687","article-title":"Compound-based Chinese medicine formula: From discovery to compatibility mechanism","volume":"254","author":"Luan","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.748872","article-title":"Pi-Dan-Jian-Qing decoction ameliorates type 2 diabetes mellitus through regulating the gut microbiota and serum metabolism","volume":"11","author":"Xie","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2019.09.007","article-title":"Antidiabetic effects of gegen qinlian decoction via the gut microbiota are attributable to its key ingredient berberine","volume":"18","author":"Xu","year":"2020","journal-title":"Genomics Proteomics Bioinf"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00918","article-title":"Linggui zhugan formula improves glucose and lipid levels and alters gut microbiota in high-fat diet-induced diabetic mice","volume":"10","author":"Wu","year":"2019","journal-title":"Front Physiol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1872134","article-title":"JinQi jiangtang tablet regulates gut microbiota and improve insulin sensitivity in type 2 diabetes mice","volume":"2019","author":"Cao","year":"2019","journal-title":"J Diabetes Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1038\/s41598-018-22094-2","article-title":"Xiexin tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota","volume":"8","author":"Wei","year":"2018","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112032","article-title":"Xiexin tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism","volume":"241","author":"Xiao","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154264","article-title":"Simiao wan modulates the gut microbiota and bile acid metabolism during improving type 2 diabetes mellitus in mice","volume":"104","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"B148","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.phrs.2018.01.011","article-title":"Effects of qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology","volume":"130","author":"Gao","year":"2018","journal-title":"Pharmacol Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.1038\/s41598-020-67362-2","article-title":"Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats","volume":"10","author":"Yan","year":"2020","journal-title":"Sci Rep"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16084","article-title":"Herbal formula LLKL ameliorates hyperglycaemia, modulates the gut microbiota and regulates the gut-liver axis in zucker diabetic fatty rats","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02380","article-title":"Huang-Lian-Jie-Du-Decoction ameliorates hyperglycemia and insulin resistant in association with gut microbiota modulation","volume":"9","author":"Chen","year":"2018","journal-title":"Front Microbiol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1813086","article-title":"New insights into the mechanisms of Chinese herbal products on diabetes: A focus on the \u201cBacteria-mucosal immunity-Inflammation-Diabetes\u201d axis","volume":"2017","author":"Gao","year":"2017","journal-title":"J Immunol Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01423","article-title":"A purified anthraquinone-glycoside preparation from rhubarb ameliorates type 2 diabetes mellitus by modulating the gut microbiota and reducing inflammation","volume":"10","author":"Cui","year":"2019","journal-title":"Front Microbiol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/molecules26030682","article-title":"The protective role of butyrate against obesity and obesity-related diseases","volume":"26","author":"Coppola","year":"2021","journal-title":"Molecules"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3390\/nu11081943","article-title":"The short-chain fatty acid acetate in body weight control and insulin sensitivity","volume":"11","author":"Hern\u00e1ndez","year":"2019","journal-title":"Nutrients"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/nu10101499","article-title":"Impact of diet-modulated butyrate production on intestinal barrier function and inflammation","volume":"10","author":"Bach Knudsen","year":"2018","journal-title":"Nutrients"},{"key":"B157","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1080\/10408398.2018.1542587","article-title":"Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria","volume":"59","author":"Fu","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2011.00388.x","article-title":"Propionate as a health-promoting microbial metabolite in the human gut","volume":"69","author":"Hosseini","year":"2011","journal-title":"Nutr Rev"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J Exp Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","article-title":"Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration","volume":"159","author":"Sorrentino","year":"2020","journal-title":"Gastroenterology"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30975","article-title":"Probiotic lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1072376\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:14:24Z","timestamp":1671758064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1072376\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":161,"alternative-id":["10.3389\/fimmu.2022.1072376"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1072376","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"article-number":"1072376"}}